doi: 10.3389/fendo.2021.706978 71 LingvayISumithranPCohenRVle RouxCW
Extended-release formulations may improve tolerability and can be dosed once daily with the evening meal, starting at 500-1,000 mg and titrating to a maximum of 2,000 mg daily (maximum may vary by specific product)
The clinical significance of elevations in lipase or amylase with liraglutide injection is unknown in the absence of other signs and symptoms of pancreatitis [see Warnings and Precautions (5.2)]
hedonic liking, motivational wanting, incentive salience, and cue-induced craving may involve partly dissociable neural mechanisms ( 8.3 Inter-individual variability, non-responders, atypical responses, and endpoint-dependent effects Although GLP-1RAs show broadly consistent weight-loss efficacy at the population level, their effects on eating experience appear to vary substantially between individuals ( For example, semaglutide 2.4 mg produces clinically meaningful mean weight loss in phase 3 trials, yet a minority of treated participants do not achieve conventional response thresholds ( The available literature is also not uniformly consistent with a simple model in which GLP-1RAs consistently reduce food reward, hedonic liking, or motivational drive
10.1016/s1570-0232(02)00618-9 J Chromatogr B Analyt Technol Biomed Life Sci